E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
The approval of pegfilgrastim biosimilar further strengthens Biocon’s portfolio of biosimilar products in Japan.
imphoenix82
The launch of Biocon’s Yesafili expands the availability of biosimilar aflibercept 2 mg for patients with age-related macular degeneration and other serious eye conditions in the US.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
